LLY

984.48

-0.03%↓

JNJ

242.48

+0.37%↑

ABBV

221.75

+0.94%↑

NVS

154.64

+1.01%↑

AZN

191.94

+0.96%↑

LLY

984.48

-0.03%↓

JNJ

242.48

+0.37%↑

ABBV

221.75

+0.94%↑

NVS

154.64

+1.01%↑

AZN

191.94

+0.96%↑

LLY

984.48

-0.03%↓

JNJ

242.48

+0.37%↑

ABBV

221.75

+0.94%↑

NVS

154.64

+1.01%↑

AZN

191.94

+0.96%↑

LLY

984.48

-0.03%↓

JNJ

242.48

+0.37%↑

ABBV

221.75

+0.94%↑

NVS

154.64

+1.01%↑

AZN

191.94

+0.96%↑

LLY

984.48

-0.03%↓

JNJ

242.48

+0.37%↑

ABBV

221.75

+0.94%↑

NVS

154.64

+1.01%↑

AZN

191.94

+0.96%↑

Search

Integra LifeSciences Holdings Corp

Ouvert

SecteurSoins de santé

9.09 -1.2

Résumé

Variation du prix de l'action

24h

Actuel

Min

9.03

Max

9.38

Chiffres clés

By Trading Economics

Revenu

3.7M

-1.7M

Ventes

33M

435M

Marge bénéficiaire

-0.392

Employés

4,427

EBITDA

12M

66M

Recommandations

By TipRanks

Recommandations

Vente

Prévisions sur 12 Mois

+21.75% upside

Dividendes

By Dow Jones

Prochains Résultats

4 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-170M

746M

Ouverture précédente

10.29

Clôture précédente

9.09

Sentiment de l'Actualité

By Acuity

100%

0%

335 / 351 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

15 mars 2026, 21:14 UTC

Principaux Événements d'Actualité

Week Ahead for FX, Bonds: Central Bank Decisions -2-

15 mars 2026, 21:14 UTC

Principaux Événements d'Actualité

Week Ahead for FX, Bonds: Central Bank Decisions in Focus After Jump in Energy Prices

16 mars 2026, 00:00 UTC

Principaux Événements d'Actualité

Hack on U.S. Medical Company Shows Reach of Iran's Cyber Capabilities -- WSJ

15 mars 2026, 23:45 UTC

Market Talk

Nikkei May Decline on Concerns About Prolonged Middle East Conflict -- Market Talk

15 mars 2026, 23:44 UTC

Market Talk
Principaux Événements d'Actualité

Gold Falls as Rising Energy Prices Exacerbate Inflation Worries -- Market Talk

15 mars 2026, 23:35 UTC

Market Talk
Principaux Événements d'Actualité

Oil Futures Rise on Supply Disruption Concerns -- Market Talk

15 mars 2026, 23:00 UTC

Acquisitions, Fusions, Rachats

Micron Completes Acquisition Of PSMC's Tongluo P5 Site In Taiwan >MU

15 mars 2026, 22:37 UTC

Market Talk

March Rate Hike Would Distance RBA From Government's May Budget -- Market Talk

15 mars 2026, 22:18 UTC

Market Talk

RBA's Likely Hike Motivated By Inflation, Not Middle East -- Market Talk

15 mars 2026, 22:14 UTC

Résultats

Genscript Biotech 2025 Adj Net $230.35M Vs. Adj Net $59.83M>1548.HK

15 mars 2026, 22:14 UTC

Résultats

Genscript Biotech: 2025 Loss Due to High Base Effect, One-off Unrealized Gains Seen Last Year >1548.HK

15 mars 2026, 22:14 UTC

Résultats

Genscript Biotech 2025 Rev $959.53M Vs. $594.49M >1548.HK

15 mars 2026, 22:14 UTC

Résultats

Genscript Biotech 2025 Loss $532.83M Vs. Net $2.96B >1548.HK

15 mars 2026, 22:14 UTC

Résultats

Genscript Biotech: 2025 Rev Supported by Substantial Increase in License Revenue>1548.HK

15 mars 2026, 22:00 UTC

Principaux Événements d'Actualité

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15 mars 2026, 22:00 UTC

Principaux Événements d'Actualité

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15 mars 2026, 03:00 UTC

Principaux Événements d'Actualité

For Xi, Iran War Reinforces View of U.S. as Dangerous Superpower -- WSJ

14 mars 2026, 15:00 UTC

Principaux Événements d'Actualité

Iran War Delivers Windfall to America's Oil Country -- WSJ

14 mars 2026, 02:03 UTC

Résultats

This Copper Stock Is Worth Mining for Profits -- Barrons.com

14 mars 2026, 01:32 UTC

Acquisitions, Fusions, Rachats

Bill Ackman's Pershing Square IPO Is Back On -- Barrons.com

14 mars 2026, 00:29 UTC

Acquisitions, Fusions, Rachats

13D Filings -- Barrons.com

13 mars 2026, 22:27 UTC

Market Talk
Principaux Événements d'Actualité

Bahrain Faces Uncertainty But Has Support Amid War, S&P Says -- Market Talk

13 mars 2026, 22:13 UTC

Market Talk
Principaux Événements d'Actualité

Saudi Arabia Seen as Able to Weather Iran Conflict, S&P Says -- Market Talk

13 mars 2026, 22:04 UTC

Market Talk
Principaux Événements d'Actualité

Emirate of RAK Outlook Stable Despite Iran War, S&P Says -- Market Talk

13 mars 2026, 22:00 UTC

Acquisitions, Fusions, Rachats

Trump Administration Set to Receive $10 Billion Fee for Brokering TikTok Deal -- WSJ

13 mars 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

13 mars 2026, 20:50 UTC

Market Talk
Principaux Événements d'Actualité

Financial Services Roundup: Market Talk

13 mars 2026, 20:02 UTC

Market Talk

Canada Rate Hike in 2026 Would Mark 'Extraordinarily Bad' Policy -- Market Talk

13 mars 2026, 19:50 UTC

Market Talk
Principaux Événements d'Actualité

Oil Posts Weekly Gains As Middle East Conflict Drags On -- Market Talk

13 mars 2026, 19:35 UTC

Principaux Événements d'Actualité

Oil Prices Hover Near $100. India Asks Iran to Allow 23 Tankers Through Strait of Hormuz. -- Barrons.com

Comparaison

Variation de prix

Integra LifeSciences Holdings Corp prévision

Objectif de Prix

By TipRanks

21.75% hausse

Prévisions sur 12 Mois

Moyen 11.25 USD  21.75%

Haut 13 USD

Bas 9 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Vente

5 ratings

0

Achat

3

Maintien

2

Vente

Score Technique

By Trading Central

12.75 / 16.41Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

335 / 351Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat